Cargando…
1937. Use of Paxlovid for Treatment of Acute COVID-19 and Occurrence of Post-COVID Conditions among Children and Adults at High-Risk for Severe COVID-19, April 1 - December 31, 2022
BACKGROUND: Data have suggested that treatment with Paxlovid for acute COVID-19 decreases the incidence of Post-COVID Conditions (PCC); however, results are limited to specific age groups and populations. This analysis assessed the occurrence of PCC following receipt of Paxlovid among children and a...
Autores principales: | Dalton, Alexandra F, Baca, Sarah, Raykin, Julia, Perrine, Cria, Boehmer, Tegan, Koumans, Emilia, Patel, Priti, Saydah, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677759/ http://dx.doi.org/10.1093/ofid/ofad500.2468 |
Ejemplares similares
-
Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2022) -
Long COVID and Significant Activity Limitation Among Adults, by Age — United States, June 1–13, 2022, to June 7–19, 2023
por: Ford, Nicole D., et al.
Publicado: (2023) -
The future of Paxlovid for COVID-19
por: Burki, Talha
Publicado: (2022) -
Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022
por: Shah, Melisa M., et al.
Publicado: (2022) -
Paxlovid associated with decreased hospitalization rate among adults with COVID-19 — United States, April–September 2022
por: Shah, Melisa M., et al.
Publicado: (2023)